Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003875539 | SCV004675618 | pathogenic | Nemaline myopathy 10 | 2023-04-08 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with LMOD3-related conditions. This variant is present in population databases (rs773282804, gnomAD 0.006%). This sequence change creates a premature translational stop signal (p.Ile213Asnfs*7) in the LMOD3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LMOD3 are known to be pathogenic (PMID: 25250574). |